| Application no. and date | 03770334.5 (espacenet) (Federated) (European Patent Register), 20030915 | | Patent/reg. no. and date | DK/EP 1572095, 20150610 | | Publication date | 20050914 | | Priority no. and date | US 410675 P, 20020913 | | EP pub. no. and date |
EP 1572095 20050914 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | T5044DK00 | | Inventor | STANDRING, David, 205 Gun Hill St
Milton, MA 02186, US,
SOMMADOSSI, Jean-Pierre, 7 Lowell Street
Cambridge, MA 02138, US,
SEIFFER, Maria, 8 Bridgestone Circle
Clinton, MA 01510, US,
PATTY, April, L., 28 Ashland St., No. 2
Medford, MA 02155, US | | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/70 (2006.01) , A61K 38/21 (2006.01) , A61P 31/20 (2006.01) | | Title | BETA-L-2´-DEOXYNUKLEOTIDER TIL BEHANDLING AF RESISTENTE HBV-STAMMER OG KOMBINATIONSTERAPIER | | Int. application no. | US2003029017 | | Int. publication no. | WO2004024095 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
